TY  - BOOK
AU  - Grimm,W.
AU  - Krummen,Kurt
ED  - Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik.
TI  - Stability testing in the EC, Japan and the USA: scientific and regulatory requirements (including the draft of the harmonized guideline for the EC, Japan and the USA) 
T2  - Paperback APV
SN  - 3804712150
U1  - 615.1901 21
PY  - 1993///
CY  - Stuttgart
PB  - Wissenschaftliche Verlagsgesellschaft
KW  - Drug stability
KW  - Standards
KW  - European Economic Community countries
KW  - Japan
KW  - Drug stabiltiy
KW  - United States
KW  - Excipients
KW  - congresses
KW  - Cyclodextrins
KW  - Recombinant Proteins
KW  - Polymers
KW  - ipat
N1  - Includes bibliographical references; Basic principles of stability testing/W. Grimm--Characterization and improvement of the stability behaviour of drug substances/P.H. Stahl,--Excipient compatibility, possibilities and limitations in stability prediction/D.C. Monkhouse--Prediction of the stability of drug products, new techniques and strategies/K.D. Gneuss--A critical review of HPLC, SFC and CZE in drug analysis/W. Steuer--Influence of packaging material on the stability of drug products/K. Krummen--Plastics for drug products: analysis, possible interactions and official requirements/F. Pellerin--EC guidelines for stability tests on active substances and finished products/A.C. Cartwright--The revised Japanese guidelines for stability studies/Y. Takeda--Consideration on revision of the FDA guideline for submitting documentation on the stability of human drugs and biologics/C. Kumkumian--Stability testing in relation to guidelines in the EC, Japan and USA, a recommendation/H. Moeller--The tripartite guideline for the stability testing of new active drug substances and products/T. Beaumont--General concept of stability testing/W. Grimm--Cyclodextrines: structure application, stability and their influence on the stability of drug substances/L. Szente--Stability and stability testing of drug products derived by recombinant DNA technology/H. Hoffmann
ER  -